Kurabo Industries (3106) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
10 Mar, 2026Executive summary
Revenue for the nine months ended December 31, 2024, was ¥111.9 billion, down 1.0% year-over-year.
Operating income rose 12.4% year-over-year to ¥7.1 billion, and ordinary income increased 13.9% to ¥8.5 billion.
Net income attributable to shareholders surged 36.8% year-over-year to ¥6.4 billion.
Growth in high-value-added businesses and cost management contributed to profit gains despite a slight revenue decline.
Financial highlights
Gross profit increased to ¥22.9 billion from ¥22.3 billion year-over-year.
Comprehensive income for the period was ¥10.95 billion, down 8.9% year-over-year.
EPS for the period was ¥365.03, up from ¥250.43 in the prior year.
Total assets at period-end were ¥199.5 billion, up ¥6.7 billion from the previous fiscal year-end.
Net assets increased to ¥122.9 billion, with an equity ratio of 61.0%.
Outlook and guidance
Full-year revenue forecast remains at ¥154.0 billion, up 1.8% year-over-year.
Operating income is projected at ¥9.6 billion (+4.5%), ordinary income at ¥10.8 billion (+6.0%), and net income at ¥7.5 billion (+11.3%).
No changes to previously announced guidance.
Latest events from Kurabo Industries
- Record FY24 profits; FY25 growth hinges on semiconductor recovery and textile turnaround.3106
Q4 2024 - H1 operating profit grew 13.8%, while investments target semiconductor and solar-material growth.3106
Q2 2024 - Sales and profits grew strongly, but net income fell on lower extraordinary gains; outlook revised up.3106
Q1 2027 - Net profit jumped 42.8% on extraordinary gains, with record FY3/27 growth forecast.3106
Q4 2026 - Q1 profit more than doubled year-over-year, with upwardly revised full-year guidance.3106
Q1 2025 - Record H1 profits on lower revenue; FY guidance held as shareholder returns rose.3106
Q2 2025 - FY3/25 profits rose; FY3/26 guidance signals headwinds as Accelerate ’27 targets 10% ROE.3106
Q4 2025 - Net income surged on extraordinary gains, but segment results and legal risks warrant caution.3106
Q1 2026 - Attributable profit jumped 87.5% on cross-shareholding gains despite lower sales.3106
Q2 2026